The Florey — Florey Institute of Neuroscience and Mental Health
Overview
The Florey Institute of Neuroscience and Mental Health employs approximately 600 staff and students across two sites in Melbourne’s Parkville and Heidelberg. It is affiliated with the University of Melbourne, Austin Health, and the Royal Melbourne Hospital, and investigates 20+ neurological and mental health conditions including Alzheimer’s disease, Parkinson’s disease, MND, epilepsy, multiple sclerosis, stroke, and depression.
Research is approximately 70% basic science and 30% translational, with access to MRI, MEG, and PET imaging facilities, histology, bioinformatics, and clinical trials infrastructure.
Open Science Initiatives
ENIGMA Consortium Participation
The Florey participates in the ENIGMA Consortium, specifically the ENIGMA-Epilepsy working group, contributing multisite neuroimaging data through ENIGMA’s coordinated analysis framework.
Australian Epilepsy Project (AEP)
The Florey leads the Australian Epilepsy Project, a $30M national research platform funded by the Australian Government’s Medical Research Future Fund (2021). It integrates multimodal data including MRI, genetics, and neuropsychology, and builds a FAIR-aligned national data platform across five hub sites.
ARDC Ecosystem
The Florey and AEP operate within Australia’s national research data infrastructure, coordinated by ARDC (Australian Research Data Commons), Australia’s FAIR data national infrastructure.
Connections
- Open science network: ENIGMA Consortium
- National infrastructure: ARDC